PepGen Inc. PEPG
Super Investor & Insider
1
Fondi che lo detengono
#1132
Rank consenso
1.4%
% dei portafogli
$6.2M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Viking Global Investors · Viking Global Investors | 0.02% | — | 3,482,434 | $6.2M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
PepGen Inc. is a clinical-stage biotechnology company developing oligonucleotide therapies. It advances the next generation of oligonucleotide therapeutics designed to transform the treatment of severe neuromuscular and neurologic diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1. The compan…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees56
TickerPEPG
Statistics
Market Cap$119.3M
Revenue (TTM)—
Net Income-$89.7M
Net Margin—
EPS$-2.12
P/E-0.69
P/S—
P/B0.76
EV/EBITDA0.14
ROE-68.4%
Dividend Yield—
Price$1.73
Data: Twelve Data · Revenue = mcap / P/S